Page 27 - FBL AR 2019-20
P. 27
Corporate Statutory FinanCial
overview StatementS StatementS
Further, the global animal feed market to the assets and cash of each other; the We believe that the consumer mindset,
presents a multi-year opportunity. We increased availability of resources now manufacturing infrastructure as well as
have already shifted the needle: In FY provides us with a potential war-chest research cum product development have
2016-17, animal feed accounted for around with which to grow the business in an made us growth-ready.
44% of the Vitamin D3 revenues whereas organic and inorganic manner across The time has come for Fermenta to deliver.
this increased to 56% in FY 2019-20. We the foreseeable future. As an extension
have seen a CAGR volume growth of 15% of the right-sizing of our Balance Sheet
from FY 2014-15 to FY 2019-20 in Human and monetisable assets, our credit rating
Vitamin D3 and 10% in Animal Vitamin D3. strengthened from BBB to A- (long-term Mr. Sanjay Buch
During the same period, we have seen a debt). Chairman
CAGR in value of 20% in Human Vitamin Some of the potential is already being
D3 and 23% in Animal Vitamin D3. Besides, translated into reality: even as we
the Company is positioning itself as a increased our manufacturing capacity in
dependable supplier of quality products 2019, we plan to increase the production
with excellence in service delivery, offering capacity by commencing operations at
a superior price-value proposition. Sayakha in the near future, broad-basing
In view of this large opportunity, the our manufacturing foundation with a
Company strengthened its Balance Sheet multi-year perspective. We believe that
during the last financial year through a this sustained investment across market
merger of its parent Company with the cycles moderates the premium in timing
objective to reduce costs and enhance our investments in line with market
synergy. Each Company will get access developments.
What we are
Positioned as a Growing focus on Global Integrated Increasingly asset- Focus on human
solutions provider nutraceuticals and manufacturing backwards; wider light food applications
food basket arrangements value chain
25